GoodRx Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 16, 2026, details the results of GoodRx Holdings, Inc.'s Annual Meeting of Stockholders held on that date. The meeting addressed the election of directors, ratification of the independent auditor, and advisory approval of executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
Approximately 99.4% of the combined voting power of Class A and Class B common stock was present or represented by proxy. The following proposals were approved:
- Election of Directors: Stockholders elected Wendy Barnes, Ronald E. Bruehlman, and Gregory Mondre as Class III directors for a term expiring in 2029. All three candidates received overwhelming support with over 2.37 billion votes "For" each.
- Ratification of Auditor: Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The proposal received 2,429,055,999 votes "For" versus 335,716 "Against."
- Executive Compensation: Stockholders approved, on an advisory basis, the compensation of named executive officers. The proposal received 2,363,913,370 votes "For" versus 23,702,520 "Against."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the final vote counts for the annual meeting proposals.
Investor Verification Checklist
- Verify the specific terms of the Class III director elections and their expiration dates (2029).
- Confirm the appointment of KPMG LLP for the fiscal year ending December 31, 2026, in subsequent financial reports.
- Review the Definitive Proxy Statement filed on April 29, 2026, for detailed context on the executive compensation advisory vote.
- Monitor the company's Class A and Class B share structure, noting the 10-to-1 voting power difference for Class B shares.